Of these patients, 16 were receiving type 1 diabetes treatment (30.2%); 11 were receiving type 2 diabetes treatment without insulin treatment (20.8%); and 26 were receiving type 2 diabetes treatment with insulin (49.0%). The gene discussed is INS; the disease is type 2 diabetes mellitus.